This HTML5 document contains 141 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n16http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n3http://linked.opendata.cz/ontology/sukl/
n13http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0147587/price-of-originator/
n11http://linked.opendata.cz/resource/sukl/specialization-restriction/
n5http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0147587/reimbursement/
skoshttp://www.w3.org/2004/02/skos/core#
n6http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0147587/
n12http://linked.opendata.cz/resource/sukl/indgroup/
n18http://linked.opendata.cz/resource/sukl/packing/
n4http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0147587/core-reimbursement/
n17http://linked.opendata.cz/resource/sukl/company/
n9http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0147587/price/
n10http://linked.opendata.cz/resource/sukl/active-ingredient/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/sukl/registration-state/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/sukl/df/
n7http://linked.opendata.cz/resource/atc/

Statements

Subject Item
n2:0147587
rdf:type
n3:MedicinalProductPackaging
dcterms:title
LICOBONDRAT 150 MG POTAHOVANÉ TABLETY
skos:notation
0147587
n3:hasATCCode
n7:M05BA06
n3:hasActiveIngredient
n10:NATRII-IBANDRONAS-MONOHYDRICUS
n3:hasDefinedDailyDose
n6:ddd
n3:hasDosageForm
n14:TBL-FLM-POR
n3:hasPackagingSize
1
n3:hasPacking
n18:BLI
n3:hasRegistrationHolder
n17:LLIE
n3:hasRegistrationState
n8:B
n3:hasRouteOfAdministration
n16:POR
n3:hasStrength
150MG
n3:hasIndicationGroup
n12:87
n3:hasSpecializationRestriction
n11:GYN n11:END n11:INT n11:REV n11:ORT
n3:containsDefinedDailyDoses
30.0
n3:hasRegistrationCode
87/ 283/11-C
n3:hasTitleSupplement
POR TBL FLM 1X150MG
n3:containsUsualTherapeuticalDailyDoses
30
n3:hasCoreReimbursementSpecification
n4:2015-04-01 n4:2015-04-02 n4:2013-08-01 n4:2013-08-03 n4:2013-11-01 n4:2013-12-01 n4:2013-09-01 n4:2013-10-01 n4:2014-03-01 n4:2014-04-01 n4:2014-01-01 n4:2014-02-01 n4:2014-06-13 n4:2014-07-01 n4:2014-05-01 n4:2014-06-01 n4:2014-09-01 n4:2014-10-01 n4:2014-07-03 n4:2014-08-01 n4:2014-11-19 n4:2014-12-01 n4:2014-10-02 n4:2014-11-01 n4:2015-02-01 n4:2015-03-01 n4:2015-01-01 n4:2015-01-13 n4:2015-05-01
n3:hasIndicationRestriction
P
n3:hasPriceOfOriginatorSpecification
n13:2015-04-02 n13:2015-05-01 n13:2015-03-01 n13:2015-04-01 n13:2015-01-13 n13:2015-02-01 n13:2014-12-01 n13:2015-01-01 n13:2014-11-01 n13:2014-11-19 n13:2014-10-01 n13:2014-10-02 n13:2014-08-01 n13:2014-09-01 n13:2014-07-01 n13:2014-07-03 n13:2014-06-01 n13:2014-06-13 n13:2014-04-01 n13:2014-05-01 n13:2014-02-01 n13:2014-03-01 n13:2013-12-01 n13:2014-01-01 n13:2013-10-01 n13:2013-11-01 n13:2013-08-03 n13:2013-09-01 n13:2013-08-01
n3:hasPriceSpecification
n9:2015-05-01 n9:2014-11-19 n9:2014-12-01 n9:2015-01-01 n9:2015-01-13 n9:2015-02-01 n9:2015-03-01 n9:2015-04-01 n9:2015-04-02 n9:2014-06-13 n9:2014-07-01 n9:2014-07-03 n9:2014-08-01 n9:2014-09-01 n9:2014-10-01 n9:2014-10-02 n9:2014-11-01 n9:2013-11-01 n9:2013-12-01 n9:2014-01-01 n9:2014-02-01 n9:2014-03-01 n9:2014-04-01 n9:2014-05-01 n9:2014-06-01 n9:2013-08-01 n9:2013-08-03 n9:2013-09-01 n9:2013-10-01
n3:hasReimbursementSpecification
n5:2015-04-02 n5:2015-05-01 n5:2014-10-01 n5:2014-10-02 n5:2014-08-01 n5:2014-09-01 n5:2014-12-01 n5:2015-01-01 n5:2014-11-01 n5:2014-11-19 n5:2014-04-01 n5:2014-05-01 n5:2014-02-01 n5:2014-03-01 n5:2014-07-01 n5:2014-07-03 n5:2014-06-01 n5:2014-06-13 n5:2013-08-03 n5:2013-09-01 n5:2013-08-01 n5:2013-12-01 n5:2014-01-01 n5:2013-10-01 n5:2013-11-01 n5:2015-03-01 n5:2015-04-01 n5:2015-01-13 n5:2015-02-01
n3:hasUsualTherapeuticalDailyDose
n6:utdd